Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • The Discussion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Health

Lilly’s bamlanivimab COVID-19 drug dubbed as effective for preventing infection

Staff Writer
Staff Writer 1 year ago
Updated 2021/05/12 at 6:20 PM
Share
SHARE

The American-based pharmaceutical giant Eli Lilly released their findings on what they dubbed as an effective antibody drug for the prevention of COVID-19 infection.

Conducted with the National Institutes of Health, the drug, known as bamlanivimab, was given to over 1,000 people at nursing homes and other long-term facilities.

Most of the participants had tested negative for infection at the initial phase of the drug’s administration.

Bamlanivimab was administered via the intravenous route; the group receiving the antibody-drug was then compared to a placebo group.

Among residents and staff at the nursing homes, bamlanivimab proved to be effective at lowering the risk of COVID-19 infection, by up to 80%, according to researchers.

The findings were released as the COVID-19 pandemic continues to affect the lives across many regions of the world, with the United States counting the highest number of confirmed cases globally.

In late-2020, the Food and Drug Administration had given the nod for the use of Lilly’s antibody-drug to treat adolescents with minor cases of infection.

Since the inception of the pandemic, however, only a handful of pharmaceutical giants have managed to receive emergency approval for safe widespread distribution within the U.S., which includes Pfizer-BioNTech, Moderna, and Lilly.

Photo: Lauren Chapman

You Might Also Like

Study shows the likely outcomes of very preterm born children

Researchers find that stress accelerates immune aging

Study finds heavy drinkers are significantly more likely to smoke

Researchers suggest menthol cigarettes may raise the possibility of youth smoking and addiction

Childhood obesity epidemic may not be effectively mitigated through just diet and exercise

TAGGED: bamlanivimab, COVID-19, Eli Lilly, pandemia
Staff Writer January 21, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Europeans optimistic of Joe Biden over trans-Atlantic relations amid post-election
Next Article How abnormal hyperactivation may be the first hallmark indication of Alzheimer’s disease

Recommended

Health

Study shows the likely outcomes of very preterm born children

1 Min Read
Health

Researchers find that stress accelerates immune aging

2 Min Read
Health

Study finds heavy drinkers are significantly more likely to smoke

1 Min Read
Health

Researchers suggest menthol cigarettes may raise the possibility of youth smoking and addiction

1 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?